相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Thymidylate synthase O-GlcNAcylation: a molecular mechanism of 5-FU sensitization in colorectal cancer
Ninon Very et al.
ONCOGENE (2022)
Clocks, cancer, and chronochemotherapy
Aziz Sancar et al.
SCIENCE (2021)
5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition
Chinmayee Sethy et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Circadian clock: a regulator of the immunity in cancer
Zhen Zhang et al.
CELL COMMUNICATION AND SIGNALING (2021)
Clocking cancer: the circadian clock as a target in cancer therapy
Francesca Battaglin et al.
ONCOGENE (2021)
BMAL1 regulates mitochondrial fission and mitophagy through mitochondrial protein BNIP3 and is critical in the development of dilated cardiomyopathy
Ermin Li et al.
PROTEIN & CELL (2020)
5-Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes
Sabrina Blondy et al.
CANCER SCIENCE (2020)
A genome-scale CRISPR-Cas9 screening in myeloma cells identifies regulators of immunomodulatory drug sensitivity
Jiye Liu et al.
LEUKEMIA (2019)
Integrative analysis of pooled CRISPR genetic screens using MAGeCKFlute
Binbin Wang et al.
NATURE PROTOCOLS (2019)
ABHD5 blunts the sensitivity of colorectal cancer to fluorouracil via promoting autophagic uracil yield
Juanjuan Ou et al.
NATURE COMMUNICATIONS (2019)
Aryl hydrocarbon receptor nuclear translocator-like (ARNTL/BMAL1) is associated with bevacizumab resistance in colorectal cancer via regulation of vascular endothelial growth factor A
Elke Burgermeister et al.
EBIOMEDICINE (2019)
The circadian protein CLOCK regulates cell metabolism via the mitochondrial carrier SLC25A10
Tingting Cai et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2019)
Medicine in the Fourth Dimension
Christopher R. Cederroth et al.
CELL METABOLISM (2019)
Periodic Oxaliplatin Administration in Synergy with PER2-Mediated PCNA Transcription Repression Promotes Chronochemotherapeutic Efficacy of OSCC
Qingming Tang et al.
ADVANCED SCIENCE (2019)
Emerging science of chronotherapy offers big opportunities to optimize drug delivery
David Adam
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
CRISPR/Cas9 library screening for drug target discovery
Morito Kurata et al.
JOURNAL OF HUMAN GENETICS (2018)
The MiR-135b-BMAL1-YY1 loop disturbs pancreatic clockwork to promote tumourigenesis and chemoresistance
Weiliang Jiang et al.
CELL DEATH & DISEASE (2018)
Physiologic Medium Rewires Cellular Metabolism and Reveals Uric Acid as an Endogenous Inhibitor of UMP Synthase
Jason R. Cantor et al.
CELL (2017)
LASP1-S100A11 axis promotes colorectal cancer aggressiveness by modulating TGFβ/Smad signaling
Ya Niu et al.
SCIENTIFIC REPORTS (2016)
Overexpression of the Circadian Clock Gene Bmal1 Increases Sensitivity to Oxaliplatin in Colorectal Cancer
Zhao-lei Zeng et al.
CLINICAL CANCER RESEARCH (2014)
Improved vectors and genome-wide libraries for CRISPR screening
Neville E. Sanjana et al.
NATURE METHODS (2014)
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
Ophir Shalem et al.
SCIENCE (2014)
CircaDB: a database of mammalian circadian gene expression profiles
Angel Pizarro et al.
NUCLEIC ACIDS RESEARCH (2013)
The circadian molecular clock creates epidermal stem cell heterogeneity
Peggy Janich et al.
NATURE (2011)
Circadian Timing in Cancer Treatments
Francis Levi et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
Genome-Wide Profiling of the Core Clock Protein BMAL1 Targets Reveals a Strict Relationship with Metabolism
Fumiyuki Hatanaka et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Selective protection by uridine of growth inhibition by 5-fluorouracil (5FU) mediated by 5FU incorporation into RNA, but not the thymidylate synthase mediated growth inhibition by 5FU-leucovorin
G. Codacci-Pisanelli et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2008)
Circadian clock coordinates cancer cell cycle progression, thymidylate synthase, and 5-fluorouracil therapeutic index
Patricia A. Wood et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer:: The European Organisation for Research and Treatment of Cancer Chronotherapy group
Sylvie Giacchetti et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Pharmacogenetics of anticancer drug sensitivity in pancreatic cancer
Elisa Giovannetti et al.
MOLECULAR CANCER THERAPEUTICS (2006)
5-Fluorouracil: Mechanisms of action and clinical strategies
DB Longley et al.
NATURE REVIEWS CANCER (2003)
Clinical pharmacokinetics of 5-fluorouracil with consideration of chronopharmacokinetics
G Milano et al.
CHRONOBIOLOGY INTERNATIONAL (2002)
分享论文
